Skip to main content

Fallon Marie E.'s Form 4 filing

Ginkgo Bioworks Holdings, Inc. (DNA) · filed May 4, 2023

Accession no.
0001127602-23-014600
Filed
May 4, 2023
Trade date
May 1-2, 2023
Filing delay
3 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $9.28K. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Fallon Marie E.CIK 0001883686Officer (See remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2023Class A Common StockMOption exerciseAcquired+13,683–F1–187,026Direct
May 1, 2023Class A Common StockMOption exerciseAcquired+3,750–F1–190,776Direct
May 1, 2023Class A Common StockMOption exerciseAcquired+307–F3–191,083Direct
May 2, 2023Class A Common StockSSaleDisposed−8,073$1.15−$9,283.95183,010Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 1, 2023Class A Common StockMOption exerciseDisposed−13,683–F1–357,645Direct
May 1, 2023Class A Common StockMOption exerciseDisposed−3,750–F1–172,500Direct
May 1, 2023Class A Common StockMOption exerciseDisposed−307–F6–50,612Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

F3

Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.

Referenced by the price of 1 transaction in Table I.

F6

Includes shares of Class B Common Stock that are subject to vesting conditions.

Referenced by the price of 1 transaction in Table II.

Remarks

Chief Accounting Officer

Read the full filing on SEC EDGAR (opens in a new tab)